Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
4, 5 and 6
Milk-exosome based pH/light sensitive drug system to enhance anticancer activity against oral squamous cell carcinoma
PMC 1828602
Of the DAC form a different molecule: two randomised, placebo-controlled, double-blind ascending-dose trials in healthy adults found that a single subcutaneous injection raised mean plasma GH 2- to 10-fold for six days or more, and mean IGF-1 1.5- to 3-fold for 911 days, with an estimated half-life of 5.88.1 days [2]
US$ 25.51
US$ 26.78
US$ 27.26
:max_bytes(150000):strip_icc()/HDC-GettyImages-2195485788-299e147644524b339a084114355dff83.jpg)
US$ 26.54
